Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 145
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
Healthline – Mental Health Breakthrough: The Therapeutic Benefits of Psychedelics
PsychCentral – All About Psychedelic Therapy
PsychCentral – Microdosing Psychedelics Linked to Lower Anxiety, Depression, Stress
atai Life Sciences Reports Third Quarter 2022 Financial Results and Business...
Death, Dying, and Psychedelics
5-HT2A Virtual Chemical Screen Produces New Candidate Antidepressants
PT371 – The Trickster Archetype and the Need for Comic Relief
Reunion Neuroscience Schedules Fiscal Second Quarter 2023 Conference Call for Monday,...
Eyes on Oregon: Special Edition
Load more